Thomson Reuters
TRI Nasdaq Research & Consulting Services Financials FY2016βFY2025
Thomson Reuters' revenue rose 3.0% to $7.5 billion in fiscal 2025. Its operating margin was 28.5%, down from 29.1% a year earlier. Free cash flow was $2.0 billion, up 9.0%. It paid out $1.0 billion in dividends and buybacks, 50% of free cash flow. The diluted share count fell 0.4%.
Last close Β· Oct 23, 2026
$123.17
0.1%About these figures. Thomson Reuters is a foreign company: it files an annual report on Form 40-F, prepared under international accounting standards (IFRS), instead of a 10-K, and no quarterly reports, so this page has fiscal years only. Its shares trade in the US as American depositary shares (ADSs), and one ADS can stand for several ordinary shares, so per-share figures are per ordinary share and the page has no market value, P/E or valuation model.
What Thomson Reuters does
No business description yet.
- Legal name
- THOMSON REUTERS CORPORATION
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001193125-26-094222
0001075124
Revenue and margins
Thomson Reuters had $7.5B of revenue in fiscal 2025, up 3.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β2.4% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $2.0B in fiscal 2025, 27.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Thomson Reuters returned $1.0B to shareholders in fiscal 2025, 50% of free cash flow. The diluted share count fell 0.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Thomson Reuters can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $778M | $1.1B | $1.3B | $2.0B | $511M |
| Debt incl. finance leases | $3.8B | $6.4B | $3.6B | $3.8B | $2.9B |
| Net debt / EBITDA | 2.1x | 2.7x | 1.0x | 0.8x | 1.1x |
| Debt / equity | 0.3x | 0.5x | 0.3x | 0.3x | 0.2x |
| Interest coverage | 7.7x | 11.1x | 12.1x | 15.1x | 18.9x |
| Current ratio | 1.0x | 0.6x | 0.9x | 1.0x | 0.6x |
| Quick ratio | 0.9x | 0.6x | 0.9x | 1.0x | 0.6x |
| Total assets | $22.1B | $21.7B | $18.7B | $18.4B | $17.9B |
| Total liabilities | $8.3B | $9.8B | $7.6B | $6.4B | $6.0B |
| Shareholders' equity | $13.8B | $11.9B | $11.1B | $12.0B | $11.9B |
| Net debt (β = net cash) | $3.0B | $5.3B | $2.4B | $1.8B | $2.4B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 8 | 6 / 8 | 6 / 8 |
| Accruals ratio | 1.8% | β1.3% | β6.3% |
| Altman Z'' | 3.77 | 4.46 | 4.10 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Thomson Reuters TRI | $55.4B | 3.0% | 28.5% | 27.0% | 11.8% | β | 6 | |
| Equifax EFX | $21.5B | 6.9% | 18.0% | 18.7% | 8.5% | 29.5x | 6 | Compare β |
| Booz Allen Hamilton BAH | $9.4B | β6.4% | 9.2% | 8.5% | 24.2% | 12.2x | 5 | Compare β |
| TransUnion TRU | $15.8B | 9.4% | 18.7% | 14.5% | 7.1% | 22.6x | 8 | Compare β |
| FTI Consulting FCN | $4.6B | 2.4% | 10.3% | 2.5% | 16.6% | 18.9x | 4 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $11.2B | $5.3B | $5.5B | $5.9B | $6.0B | $6.3B | $6.6B | $6.8B | $7.3B | $7.5B |
| Operating income | $1.4B | $1.0B | $780M | $1.2B | $1.9B | $1.2B | $1.8B | $2.3B | $2.1B | $2.1B |
| Interest expense | $339M | $327M | $259M | $155M | $156M | $161M | $165M | $193M | $140M | $113M |
| Pretax income | $3.1B | $1.3B | $4.1B | $366M | $1.2B | $7.3B | $1.6B | $3.1B | $2.1B | $1.9B |
| Income tax | β$15.0M | β$134M | $136M | β$1.2B | $71.0M | $1.6B | $259M | $417M | β$123M | $423M |
| Net income | $3.1B | $1.4B | $3.9B | $1.6B | $1.1B | $5.7B | $1.3B | $2.7B | $2.2B | $1.5B |
| Diluted EPS | $4.13 | $1.94 | $5.88 | $3.11 | $2.25 | $11.50 | $2.75 | $5.80 | $4.89 | $3.33 |
| Diluted shares | 0.75B | 0.72B | 0.67B | 0.50B | 0.50B | 0.49B | 0.48B | 0.46B | 0.45B | 0.45B |
| Cash flow | ||||||||||
| Cash from operations | $3.0B | $2.0B | $2.1B | $702M | $1.7B | $1.8B | $1.9B | $2.3B | $2.5B | $2.7B |
| Capital expenditure | β | $519M | $576M | $505M | $504M | $487M | $595M | $544M | $607M | $634M |
| Free cash flow | β | $1.5B | $1.5B | $197M | $1.2B | $1.3B | $1.3B | $1.8B | $1.9B | $2.0B |
| Depreciation and amortization | $1.0B | $995M | $110M | $154M | $184M | $177M | $140M | $116M | $113M | $111M |
| Stock-based compensation | $106M | $60.0M | $48.0M | $56.0M | $64.0M | $76.0M | $85.0M | $83.0M | $87.0M | $111M |
| Acquisitions | $112M | $2.0M | $478M | $998M | $167M | $18.0M | $191M | $1.2B | $622M | $843M |
| Share buybacks | $1.7B | $1.0B | $1.2B | $488M | $200M | $1.4B | $1.3B | $1.1B | $639M | $1.0B |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $1.7B | $1.0B | $1.2B | $488M | $200M | $1.4B | $1.3B | $1.1B | $639M | $1.0B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $2.4B | $874M | $2.7B | $825M | $1.8B | $778M | $1.1B | $1.3B | $2.0B | $511M |
| Total debt | $8.5B | $8.7B | $3.2B | $3.8B | β | $3.8B | $6.4B | $3.6B | $3.8B | $2.9B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $4.6B | $3.0B | $4.5B | $3.1B | $4.0B | $2.5B | $2.8B | $2.9B | $3.5B | $2.2B |
| Current liabilities | $4.6B | $4.8B | $2.7B | $3.2B | $2.7B | $2.6B | $4.9B | $3.2B | $3.4B | $3.5B |
| Inventory | $32.0M | $31.0M | $33.0M | $23.0M | $26.0M | $28.0M | $29.0M | $20.0M | $21.0M | $23.0M |
| Property and equipment, net | $961M | $921M | $473M | $615M | $545M | $502M | $414M | $447M | $386M | $361M |
| Total assets | $27.9B | $26.5B | $17.0B | $17.3B | $17.9B | $22.1B | $21.7B | $18.7B | $18.4B | $17.9B |
| Total liabilities | $14.6B | $12.9B | $7.8B | $7.7B | $7.9B | $8.3B | $9.8B | $7.6B | $6.4B | $6.0B |
| Shareholders' equity | $12.8B | $13.1B | $9.2B | $9.6B | $10.0B | $13.8B | $11.9B | $11.1B | $12.0B | $11.9B |
| Margins | ||||||||||
| Operating margin | 12.5% | 19.5% | 14.2% | 20.3% | 32.2% | 19.6% | 27.7% | 34.3% | 29.1% | 28.5% |
| EBITDA margin | 21.6% | 38.3% | 16.2% | 22.9% | 35.3% | 22.4% | 29.8% | 36.0% | 30.6% | 30.0% |
| Net margin | 27.7% | 26.3% | 71.5% | 26.5% | 18.8% | 89.6% | 20.2% | 39.7% | 30.5% | 20.1% |
| FCF margin | β | 28.5% | 27.0% | 3.3% | 20.7% | 20.3% | 19.9% | 26.5% | 25.5% | 27.0% |
| Returns | ||||||||||
| Return on capital | β | 5.1% | 4.9% | 10.8% | β | β | 9.0% | 13.2% | 15.5% | 11.8% |
| Return on capital employed | β | 4.6% | 4.3% | 8.4% | 13.2% | 7.1% | 10.1% | 14.5% | 13.9% | 14.5% |
| Return on equity | β | 10.8% | 35.3% | 16.7% | 11.5% | 47.8% | 10.4% | 23.5% | 19.2% | 12.6% |
| Return on assets | β | 5.1% | 18.1% | 9.1% | 6.4% | 28.4% | 6.1% | 13.3% | 11.9% | 8.3% |
| Growth | ||||||||||
| Revenue growth | β | β52.6% | 3.9% | 7.4% | 1.3% | 6.1% | 4.4% | 2.5% | 6.8% | 3.0% |
| Net income growth | β | β55.0% | 181.9% | β60.2% | β28.3% | 407.0% | β76.5% | 101.4% | β18.0% | β32.0% |
| EPS growth | β | β53.0% | 203.1% | β47.1% | β27.7% | 411.1% | β76.1% | 110.9% | β15.7% | β31.9% |
| FCF growth | β | β | β1.6% | β86.7% | 530.0% | 3.6% | 2.6% | 36.1% | 3.0% | 9.0% |
| Share count change | β | β3.8% | β7.2% | β24.8% | β0.9% | β0.7% | β1.9% | β4.3% | β2.7% | β0.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.5x | 3.8x | 0.6x | 2.2x | β | 2.1x | 2.7x | 1.0x | 0.8x | 1.1x |
| Debt / equity | 0.7x | 0.7x | 0.4x | 0.4x | β | 0.3x | 0.5x | 0.3x | 0.3x | 0.2x |
| Interest coverage | 4.1x | 3.2x | 3.0x | 7.7x | 12.4x | 7.7x | 11.1x | 12.1x | 15.1x | 18.9x |
| Current ratio | 1.0x | 0.6x | 1.7x | 1.0x | 1.5x | 1.0x | 0.6x | 0.9x | 1.0x | 0.6x |
| Quick ratio | 1.0x | 0.6x | 1.7x | 1.0x | 1.5x | 0.9x | 0.6x | 0.9x | 1.0x | 0.6x |
| Capital allocation | ||||||||||
| Capex / revenue | β | 9.8% | 10.5% | 8.6% | 8.4% | 7.7% | 9.0% | 8.0% | 8.4% | 8.5% |
| Stock comp / revenue | 1.0% | 1.1% | 0.9% | 1.0% | 1.1% | 1.2% | 1.3% | 1.2% | 1.2% | 1.5% |
| Payouts / FCF | β | 66.2% | 79.0% | 247.7% | 16.1% | 108.9% | 97.1% | 60.0% | 34.5% | 49.6% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | 7.0 | 4.0 | β | β | 4.0 | 7.0 | 6.0 | 6.0 |
| Altman Z'' | 2.2 | 1.8 | 3.2 | 2.6 | 3.5 | 3.4 | 2.4 | 3.8 | 4.5 | 4.1 |
| Accruals ratio | β | β2.3% | 8.6% | 5.0% | β3.5% | 19.6% | β2.6% | 1.8% | β1.3% | β6.3% |
Source: SEC EDGAR XBRL filings (CIK 0001075124). Data updated October 23, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.